Evidence map›Paper›PMID 40877912›Full record

ArticleBiological research2025

The unique contributions of Rab11 and Rab35 to the completion of cell division.

Paulius Gibieža, Emilija Ratkevičiūtė, Girstautė Dabkevičiūtė, Vilma Petrikaitė

Abstract read
In one paragraph

Article in Biological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paulius GibiežaLaboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukilėlių Av. 13, 50162, Kaunas, Lithuania. paulius.gibieza@lsmu.lt.ORCID http://orcid.org/0000-0003-0432-9690
Emilija RatkevičiūtėLaboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukilėlių Av. 13, 50162, Kaunas, Lithuania.
Girstautė DabkevičiūtėLaboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukilėlių Av. 13, 50162, Kaunas, Lithuania.
Vilma PetrikaitėLaboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukilėlių Av. 13, 50162, Kaunas, Lithuania.

Funding

Lietuvos Mokslo Taryba 09.3.3-LMT-K-712-23-0011
6 · The paper itself

Abstract

Rab11 and Rab35 have been implicated in large-scale intracellular membrane trafficking during the last phases of the cell cycle. Although both proteins are associated with cytokinetic abscission, they appear to perform distinct functions and give rise to different phenotypes in dividing cells. Despite a substantial body of research on each protein individually, no study to date has systematically compared Rab11 and Rab35 in the context of cancer cell division. As a result, the extent of their interrelationship and potential compensatory mechanisms remains unclear. Our data demonstrate that Rab11a, Rab11b and Rab35 expression levels are partially interrelated. We also show that Rab11 and Rab35 contribute to mitotic progression in different ways, particularly during specific stages of the M-phase. Notably, depletion of either Rab11 or Rab35 disrupts cytokinetic abscission and correlates with aberrant F-actin accumulation at the intercellular bridge. Furthermore, overexpression of related Rab proteins with overlapping functions does not rescue the cytokinetic defects caused by Rab11 or Rab35 downregulation in cancer cells. Therefore, this study aims to deepen our understanding of how Rab11 and Rab35 orchestrate the molecular events that drive the progression from late anaphase through the completion of cytokinesis.

Indexed as

Cell Divisionrab GTP-Binding ProteinsActinsCytokinesisHeLa CellsHumansMitosisrab11 GTP-Binding ProteinsTelophaseActinsrab11 GTP-Binding ProteinsRAB35 protein, humanrab GTP-Binding ProteinsAbscissionCytokinesisDivisionRab11Rab35Telophase

Identifiers

PMID40877912
PMCPMC12395799

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.